[1]曹晓春,王芳,潘贤明.茵泽温肝方治疗寒湿困脾型胆汁淤积性肝病疗效及对患者肝功能的影响[J].西部中医药,2023,36(09):106-109.[doi:10.12174/j.issn.2096-9600.2023.09.23]
　CAO Xiaochun,WANG Fang,PAN Xianming.Curative Effects of Yinze Wengan Prescription in the Treatment of Cholestatic Liver Disease of Cold-damp Encumbering Spleen Pattern and Its Influence on Patients' Liver Function[J].Western Journal of Traditional Chinese Medicine,2023,36(09):106-109.[doi:10.12174/j.issn.2096-9600.2023.09.23]
点击复制

茵泽温肝方治疗寒湿困脾型胆汁淤积性肝病疗效及对患者肝功能的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年09期
页码:
106-109
栏目:
出版日期:
2023-09-15

文章信息/Info

Title:
Curative Effects of Yinze Wengan Prescription in the Treatment of Cholestatic Liver Disease of Cold-damp Encumbering Spleen Pattern and Its Influence on Patients' Liver Function
作者:
曹晓春, 王芳, 潘贤明
山东省文登整骨医院，山东 文登 264400
Author(s):
CAO Xiaochun, WANG Fang, PAN Xianming
Shandong Wendeng Osteopathic Hospital, Wendeng 264400, China
关键词:
肝病; 胆汁淤积性; 寒湿困脾; 肝功能; 茵泽温肝方
Keywords:
liver disease;  cholestatic; cold-damp encumbering spleen pattern; liver function; prescription
分类号:
R256.41
DOI:
10.12174/j.issn.2096-9600.2023.09.23
文献标志码:
B
摘要:
目的观察茵泽温肝方治疗寒湿困脾型胆汁淤积性肝病疗效及对患者肝功能的影响。 方法将152例寒湿困脾型胆汁淤积性肝病患者依据随机数字表法分为对照组和试验组各76例，对照组在常规保肝治疗基础上给予熊去氧胆酸、腺苷蛋氨酸治疗，试验组在对照组基础上口服茵泽温肝汤，治疗3个月后比较两组患者临床疗效、血清总胆红素（total bilirubin，TBIL）、碱性磷酸酶（alkaline phosphatase，ALP）、肝纤维指标水平及肝脏硬度值终末期肝病模型评分（liver hardness value end-stage liver disease model score，MELD）、Child-pugh分级变化情况。 结果对照组与试验组总有效率分别为50.00%（38/76）、75.00%（57/76）（P＜0.05）；与治疗前相比，治疗后两组患者TBIL、ALP水平与肝纤维指标均下降，试验组下降更明显（P＜0.05）；与治疗前相比，治疗后对照组MELD评分变化不明显（P＞0.05），试验组MELD评分降低（P＜0.05）；与治疗前相比，两组Child-pugh分级均改善，试验组改善程度优于对照组（P＜0.05）。 结论茵泽温肝方能减轻寒湿困脾型胆汁淤积性肝病患者肝纤维化程度，改善肝脏硬度值，并能提高临床疗效。
Abstract:
ObjectiveTo observe curative effects of Yinze Wengan prescription in the treatment of cholestatic liver disease of cold-damp encumbering spleen pattern and its influence on patients' liver function. MethodsAll 152 patients were divided into control group and experiment group according to random number table method (n=76 cases), the control group was treated with ursodesoxycholic acid and ademetionine based on conventional liver-protecting therapy, and the experiment group took Yinze Wengan prescription orally on the foundation of the therapy the control group accepted, after three months of the treatment, to compare clinical effects, the levels of TBIL, ALP and the indexes of liver fibrosis, MELD and Child-pugh grading changes between both groups. ResultsTotal effective rates of the control group and the experiment group were 50.00%（38/76） and 75.00%（57/76） respectively (P<0.05); compared with before the treatment, the levels of TBIL and ALP, and the indexes of liver fibrosis in both groups lowered, and the decrease of the experiment group was more noticeable (P<0.05); compared with before the treatment, the changes of MELD scores were insignificant in the control group after the treatment (P>0.05), MELD scores decreased in the experiment group (P<0.05); compared with before the treatment, Child-pugh grading of the two group improved,the improvements of Child-pugh grading of the experiment group were better than these of the control group (P<0.05). ConclusionYinze Wengan prescription could relieve liver fibrosis degrees in patients with cholestatic liver disease of cold-damp encumbering spleen pattern, improve liver hardness value and raise clinical effects.

相似文献/References:

[1]高舒迪,扈晓宇△.中医药治疗酒精性肝病的辨病论治概况及研究述评[J].西部中医药,2013,26(02):122.
　GAO Shudi,HU Xiaoyu.Research Review and Survey of TCM in Treating Alcoholic Liver Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(09):122.
[2]闵光涛,李玉民,侯旭东,等.赤栀黄汤治疗胆总管结石术后胆汁淤积性黄疸35例[J].西部中医药,2012,25(08):83.
　MIN Guang-tao,LI Yu-min,HOU Xu-dong,et al.ChiZhi HuangTang in Treating 35 Cases of Cholestatic Jaundice after Choledocholithotomy[J].Western Journal of Traditional Chinese Medicine,2012,25(09):83.
[3]黄俊敏,曹安民,刘俊兰,等.山楂降脂丸合耳穴压豆法治疗脂肪性肝病超声图像变化比较[J].西部中医药,2013,26(11):127.
　HUANG Junmin,CAO Anmin,LIU Junlan,et al.Sonographic Changes of ShanZha JiangZhiWan and Ear Acupoint Bean-pressing Method in Treating Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(09):127.
[4]黄晶晶,潘哲,黄妮曼,等.从温病学理论论治肝病的研究进展[J].西部中医药,2014,27(02):142.
　HUANG Jingjing,PAN Zhe,HUANG Niman,et al.Study on Treatment for Liver Disease by the Theory of Febrile Disease Science[J].Western Journal of Traditional Chinese Medicine,2014,27(09):142.
[5]罗媛媛,张斌,蔡启茂.加味甘露消毒饮治疗早期脂肪性肝病的临床研究[J].西部中医药,2014,27(01):111.
　LUO Yuanyuan,ZHANG Bin,CAI Qimao.Clinical Study on Modified GanLu XiaoDu Drink in Treating Fatty Liver Disease at Early Stage[J].Western Journal of Traditional Chinese Medicine,2014,27(09):111.
[6]田旭东,孙平,李彦龙,等.甜菜碱对酒精性肝病大鼠肝细胞色素P450 2E1基因和蛋白表达的影响*[J].西部中医药,2014,27(07):8.
　TIAN Xudong,SUN Ping,LI Yanlong,et al.Therapeutic Effects of Betaine on the Expressions of Hepatocyte Cytochrome P450 2E1 Gene and Protein of Rats with Alcoholic Liver Disease[J].Western Journal of Traditional Chinese Medicine,2014,27(09):8.
[7]江明洁,贺劲松△.“三因制宜”理论辨治非酒精性脂肪性肝病[J].西部中医药,2018,31(10):22.
　JIANG Mingjie,HE Jinsong.Differentiating and Treating Non-alcoholic Fatty Liver Disease by the Theory of “Treatment Individualized to Patient, Season and Locality”[J].Western Journal of Traditional Chinese Medicine,2018,31(09):22.

备注/Memo

备注/Memo:
曹晓春（1981—），女，主治医师。研究方向：肝病的中医药治疗。
更新日期/Last Update: 2023-09-15